otc.pharmaceutical-business-review.comMarketing & Sales Archives - Pharmaceutical Business review

-- Pharmaceutical Business review -- -- Marketing & Sales Archives - Pharmaceutical Business review Pharmaceutical Business review is using cookies Continue Learn More Close ☰ Search × Home About Us Add Company Advertise with us Contact us Events Suplpiers News Clinical Trials Drug Discovery Packaging & Supply Chain Production & Sales Regulation Advertise With Us Advertise on our extensive network of industry websites and newsletters. Get the PBR newsletter Sign up to our free email to get all the latest PBR news. Home Drug Discovery Drug Discovery Research & Development Pre-clinical Studies Research & Development Pfizer acquires Amplyx Pharmaceuticals Research & Development NIAID grants $2.5m to 12 institutes for bacteriophage therapy research Research & Development Clinical Trials Biotechnology Clinical Trials Clinical Trials Patient Enrollment Human Trials Patient Enrollment AM-Pharma enrols first patients in Covid-19 phase III trial Clinical Trials Patient Enrollment FSD Pharma doses first patient in phase 2 Covid-19 trial of FSD201 Clinical Trials Patient Enrollment Regulation Regulation Drug Filing Approvals Rejections Marketing Authorisation Patents Lawsuits Drug Filing Takeda submits New Drug Application for lanadelumab in Japan Drug Filing Approvals Haematology Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US Regulation Drug Filing Production & Sales Production & Sales Production & Sales Manufacturing Launches Recalls Marketing & Sales Manufacturing SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China Manufacturing Marketing & Sales Neurology Biogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806 Manufacturing Osteoarthritis Packaging & Supply Chain Packaging & Supply Chain Packaging Cold Chain Distribution Storage Packaging Gerresheimer Packaging PCI Pharma announces bottling line expansion at Rockford site Packaging & Supply Chain Packaging Suppliers Suppliers A-Z Suppliers Products & Services Videos White Papers No data found Events -- Register Log In Production & Sales - Marketing & Sales 15 Apr 2021 Neurology Manufacturing SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China By PBR Staff Writer Biopharmaceutical company SciNeuro Pharmaceuticals has signed an exclusive license agreement with Eli Lilly and Company for the development and commercialisation of alpha-synuclein targeted antibody therapies in Greater China. 19 Mar 2021 Neurology Manufacturing Anima signs new strategic collaboration deal with Takeda By PBR Staff Writer Anima Biotech has announced its new strategic collaboration deal with Takeda Pharmaceutical Company for the discovery and development of new medicines to combat genetically defined neurological diseases. 19 Mar 2021 Disease Specific Immunochemistry Manufacturing Drug Manufacturing Boston Pharmaceuticals signs three-year agreement with GSK By PBR Staff Writer The US-based clinical stage biopharmaceutical company Boston Pharmaceuticals has announced the signing of a unique three-year out-license and option agreement with the UK-based GlaxoSmithKline (GSK). 18 Feb 2021 Production & Sales Marketing & Sales Pfizer, BioNTech to supply 200 million more Covid-19 vaccine doses to Europe By PBR Staff Writer Pfizer and BioNTech have entered into an agreement with the European Commission (EC) to supply an additional 200 million doses of their Covid-19 vaccine. 24 Dec 2020 Production & Sales Marketing & Sales Merck announces supply agreement with US for initial doses of investigational biological therapy to treat Covid-19 By PBR Staff Writer Merck, known as MSD outside the United States and Canada, announced it has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an investigational biological therapeutic (CD24Fc, to be named MK-7110) upon approval or Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). 24 Dec 2020 Production & Sales Marketing & Sales Pfizer, BioNTech agree to supply additional 100 million Covid-19 vaccine doses to US By PBR Staff Writer Pfizer and BioNTech have entered into a second agreement with the US government to supply an additional 100 million doses of their Covid-19 vaccine. 15 Dec 2020 Production & Sales Marketing & Sales Moderna confirms agreement with Singapore for supply of mRNA vaccine against Covid-19 By PBR Staff Writer Moderna confirmed that the Company concluded an agreement with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support ongoing efforts to secure access to a safe and effective COVID-19 vaccine for the people of Singapore. 03 Dec 2020 Production & Sales Marketing & Sales Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19 By PBR Staff Writer The US government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. The purchase agreement is for $812.5 million and the doses will be delivered through January 31, 2021, with at least 350,000 of the additional doses delivered in December 2020. 02 Dec 2020 Production & Sales Marketing & Sales Boston Scientific signs agreement to divest BTG Specialty Pharmaceuticals business By PBR Staff Writer Boston Scientific announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 million in cash. 30 Nov 2020 Production & Sales Marketing & Sales Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan By PBR Staff Writer Dr. Reddy’s Laboratories has entered into a definitive agreement with Glenmark Pharmaceuticals to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along-with rights to the trademarks, dossiers and patents for the territories mentioned. -- -- About Us Advertise with us Contact us PRIVACY POLICY TERMS AND CONDITIONS © PBR 2021. Part of Progressive Trade Media Ltd. Lost Password Back ⟶ Login Register Get new password Lost Password? Login Registration is disabled....